SCHEMBL16255604

SCHEMBL16255604

Cc1cc(C2CCN(N)CC2)ccc1Nc1ncc(Cl)c(NCc2cccc3c2C(C)(C)C(=O)N3)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT4 P35916 1/20 0.41
▸ PTK2 Q05397 1/20 0.41
▸ EGFR P00533 10/20 0.40
▸ ALK Q9UM73 5/20 0.40
▸ INSR P06213 1/20 0.40
▸ IGF1R P08069 1/20 0.40
▸ LRRK2 Q5S007 2/20 0.39
▸ MET P08581 1/20 0.38
▸ JAK3 P52333 2/20 0.37
▸ JAK2 O60674 2/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TTK P33981 1/20 0.37
▸ FLT3 P36888 1/20 0.37
▸ TXK P42681 1/20 0.37
▸ BLK P51451 1/20 0.37
▸ BTK Q06187 1/20 0.37
▸ ITK Q08881 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ TNK2 Q07912 1/20 0.37
▸ MAPK3 P27361 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10205209 0.93 ALK (0.47) FLT4PTK2EGFRALKINSR
SCHEMBL10207086 0.93 EGFR (0.41) FLT4PTK2EGFRALKINSR
SCHEMBL10205153 0.92 LRRK2 (0.44) FLT4PTK2EGFRALKINSR
SCHEMBL14331699 0.91 EGFR (0.43) EGFRALKINSRIGF1RLRRK2
SCHEMBL16255628 0.91 EGFR (0.39) FLT4PTK2EGFRALKINSR
SCHEMBL10205156 0.90 EGFR (0.47) PTK2EGFRALKINSRIGF1R
SCHEMBL10205935 0.90 ALK (0.45) FLT4PTK2EGFRALKINSR
SCHEMBL10205190 0.90 EGFR (0.51) FLT4PTK2EGFRALKINSR
SCHEMBL14331737 0.89 EGFR (0.40) FLT4PTK2EGFRALKINSR
SCHEMBL10207045 0.89 ALK (0.47) FLT4PTK2EGFRALKINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655358-B1 OXINDOLOPYRIMIDINE AS IGF1R RECEPTOR INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 — — EP disclosed
Send feedback